PL BioScience has advanced an oral BPC-157 formulation (designated PL-10) to Phase II clinical trials for inflammatory bowel disease representing the most clinically advanced human development of oral BPC-157 to date.3 Human peer-reviewed results from these trials are pending, but the preclinical rationale is strong
Since your syringe is just 5ml - you can do two 3ml Bac Water Transfers
Often only TSH gets measured, which doesnt tell us very much about your thyroids functioning
*Intended for use with the LifeShield Blunt Cannula
Safety Considerations for Injured Individuals While peptides like BPC 157 and TB 500 appear promising, they are not without risks: Side effects reported include nausea, headaches, dizziness, and injection-site reactions
Its also best to begin this injection treatment with a professional at first, so that you can be sure that it is administered correctly